BACKGROUND: The aim of the present study was to examine the association between antidepressant use, diagnosed depression, and new-onset diabetes among elderly Medicare beneficiaries. METHODS: Longitudinal data from merged survey and claims from the nationally representative Medicare Current Beneficiary Survey(MCBS) from 1999 to 2005 were used. Diabetes incidence was extracted from claims and survey data over a 3-year period. Data regarding depression and antidepressant use over time were obtained. Multivariate logistic regression analysis was used to examine associations between antidepressant use, depression, and new-onset diabetes, adjusted for demographic, socioeconomic, and lifestyle risk factors. Analyses accounted for the complex design of the MCBS. RESULTS: The incident diabetes rate was 4.8% for those "without depression and without antidepressants" and 9.5% for those with any antidepressant use in all 3 years and diagnosed depression". Compared with Medicare beneficiaries who did not report any antidepressant use, beneficiaries reporting antidepressant use in all 3 years were 50% more likely to have new-onset diabetes. However, when diagnosed depression was entered in the model, there was no significant association between long-term antidepressant use and new-onset diabetes. Medicare beneficiaries with any depression were twice as likely as those without depression to develop diabetes (adjusted odds ratio 2.04; 95% confidence interval 1.51, 2.75). CONCLUSIONS: Depression independently increased the risk of developing diabetes in the MCBS population, although there is no evidence of an association between antidepressant use and new-onset diabetes. If replicated, these results have significant clinical implications.
BACKGROUND: The aim of the present study was to examine the association between antidepressant use, diagnosed depression, and new-onset diabetes among elderly Medicare beneficiaries. METHODS: Longitudinal data from merged survey and claims from the nationally representative Medicare Current Beneficiary Survey(MCBS) from 1999 to 2005 were used. Diabetes incidence was extracted from claims and survey data over a 3-year period. Data regarding depression and antidepressant use over time were obtained. Multivariate logistic regression analysis was used to examine associations between antidepressant use, depression, and new-onset diabetes, adjusted for demographic, socioeconomic, and lifestyle risk factors. Analyses accounted for the complex design of the MCBS. RESULTS: The incident diabetes rate was 4.8% for those "without depression and without antidepressants" and 9.5% for those with any antidepressant use in all 3 years and diagnosed depression". Compared with Medicare beneficiaries who did not report any antidepressant use, beneficiaries reporting antidepressant use in all 3 years were 50% more likely to have new-onset diabetes. However, when diagnosed depression was entered in the model, there was no significant association between long-term antidepressant use and new-onset diabetes. Medicare beneficiaries with any depression were twice as likely as those without depression to develop diabetes (adjusted odds ratio 2.04; 95% confidence interval 1.51, 2.75). CONCLUSIONS:Depression independently increased the risk of developing diabetes in the MCBS population, although there is no evidence of an association between antidepressant use and new-onset diabetes. If replicated, these results have significant clinical implications.
Authors: Hua Chen; Jaxk H Reeves; Jack E Fincham; William K Kennedy; Jeffrey H Dorfman; Bradley C Martin Journal: J Clin Psychiatry Date: 2006-06 Impact factor: 4.384
Authors: Usha Sambamoorthi; Bevanne Bean-Mayberry; Patricia A Findley; Elizabeth M Yano; Ranjana Banerjea Journal: Am J Manag Care Date: 2010-09 Impact factor: 2.229
Authors: Antonio Campayo; Peter de Jonge; Juan F Roy; Pedro Saz; Concepción de la Cámara; Miguel A Quintanilla; Guillermo Marcos; Javier Santabárbara; Antonio Lobo Journal: Am J Psychiatry Date: 2010-02-01 Impact factor: 18.112
Authors: Richard R Rubin; Yong Ma; Mark Peyrot; David G Marrero; David W Price; Elizabeth Barrett-Connor; William C Knowler Journal: Diabetes Care Date: 2010-08-30 Impact factor: 19.112
Authors: Yunsheng Ma; Raji Balasubramanian; Sherry L Pagoto; Kristin L Schneider; Annie L Culver; Barbara Olendzki; Lesley Tinker; Simin Liu; Monika Safford; Deidre M Sepavich; Milagros C Rosal; Judith K Ockene; Mercedes Carnethon; Martha Zorn; James R Hébert Journal: Diabetes Care Date: 2011-09-12 Impact factor: 19.112
Authors: Thi Thu Ha Nguyen; Anne Roussin; Vanessa Rousseau; Jean-Louis Montastruc; François Montastruc Journal: Drug Saf Date: 2018-11 Impact factor: 5.606
Authors: Varsha G Vimalananda; Julie R Palmer; Hanna Gerlovin; Lauren A Wise; James L Rosenzweig; Lynn Rosenberg; Edward A Ruiz-Narváez Journal: Diabetes Care Date: 2014-05-01 Impact factor: 19.112
Authors: Yen-Hao Tran; Catharina C M Schuiling-Veninga; Jorieke E H Bergman; Henk Groen; Bob Wilffert Journal: CNS Drugs Date: 2017-06 Impact factor: 5.749